r.bruun
TL2 · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 7 April 2025 · last posted 1d
88 posts, newest first. Showing up to 150.
-
Insurance and replacement policies, compared Replied, post #121 · Sourcing › Logistics · 26 Jul 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. I would put a moderate confidence…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 7 likes On post #27 — agreed on the reasoning, with one qualification. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
What a regulator's shortage notice actually authorises Replied, post #7 · Sourcing › Regulatory · 12 Jul 2026 · 1 like Narrowing post #4, because the general version has more than one answer. Generic or biosimilar entry depends on patent and exclusivity positions that are…
-
NHS criteria and how they are applied in practice Replied, post #25 · Regional › UK & Ireland · 10 Jul 2026 · 0 likes NHS criteria has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #71 · Analytics › Impurities & related substances · 9 Jul 2026 · 0 likes Answering the question post #69 raises rather than the one it answers. Practical experience of Endotoxin, offered as one case with the conditions stated, not as a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2026 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Micro-titration: a disputed topic, argued properly Replied, post #96 · Practice › Dosing & titration · 27 Jun 2026 · 0 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. What I can speak to on micro-titration is narrow, so I will keep it narrow rather…
-
Restarting after a long gap: what the labelling implies Started this topic · Practice › Dosing & titration · 24 Jun 2026 · 2 likes Posting this under the heading it deserves: Restarting after a long gap: what the labelling implies Everything below is what sits behind that. I have read the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #74 · Compounds › Semaglutide · 22 Jun 2026 · 15 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Why pulsatile secretion matters for interpreting secretagogue claims Started this topic · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 30 likes Why pulsatile secretion matters for interpreting secretagogue claims — that is the question, and I have not found it answered plainly anywhere I have looked. A…
-
Micronutrient adequacy at low total intake Replied, post #27 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 7 likes Tracking intake for a week rather than permanently is usually enough to find out whether there is a problem. Permanent tracking has its own costs. Adding this to the…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #89 · Sourcing › Red flags · 6 Jun 2026 · 0 likes A certificate that reports a specification in the result column is a documentation defect, and it is a defect people should be able to recognise without it being called…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #62 · Devices › Syringes & needles · 5 Jun 2026 · 6 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Injecting into an area that has become firm: why not to Replied, post #14 · Practice › Administration · 4 Jun 2026 · 22 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Two…
-
CJC-1295 with and without DAC: what the modification does Replied, post #69 · Compounds › Secretagogues & GH axis · 28 May 2026 · 20 likes On CJC-1295: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #20 · Analytics › Home & field testing · 14 May 2026 · 10 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
A parcel stationary at a customs facility for nine days Replied, post #57 · Sourcing › Logistics · 8 May 2026 · 7 likes Answering the question post #55 raises rather than the one it answers. The useful distinction on parcel stationary is between what was measured and what was inferred…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #57 · Evidence › Journal club · 7 May 2026 · 5 likes Sensible. I would want the same detail before I acted on it either.
-
Forced degradation studies: designing one that is informative Replied, post #47 · Analytics › Method validation · 1 May 2026 · 15 likes Forced degradation studies sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side,…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #67 · Evidence › Trials · 1 May 2026 · 32 likes Adding the measurement that post #64 says would settle it. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #36 · Evidence › Preprints · 22 Apr 2026 · 1 like This follows post #34 rather than contradicting it. A preprint that has been up for two years without appearing in a journal is telling you something, and it is not…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #8 · Wellbeing › Sleep · 3 Apr 2026 · 0 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #84 · Regional › UK & Ireland · 20 Mar 2026 · 1 like What I can speak to on pharmacy supply is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #64 · Practice › Storage & stability · 15 Mar 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I have separated what I observed from…
-
Adolescents: a distinct evidence base — one year on Replied, post #74 · Clinical › Special populations · 13 Mar 2026 · 12 likes Athletes and people in substantial training loads are effectively unstudied, and the questions asked here about performance have no trial evidence behind them at all.…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #23 · Start Here › Welcome · 10 Mar 2026 · 26 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
Second pass at: Identical chromatograms across two different lots Replied, post #52 · Sourcing › Red flags · 9 Mar 2026 · 0 likes Taking post #49 at face value and following it one step further. The most useful contribution to this subcategory is a resolved case written up with the resolution,…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #110 · Access › Pricing · 8 Mar 2026 · 1 like Where a price is quoted per vial, the fill has to be stated for the comparison to mean anything.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #119 · Access › International · 19 Feb 2026 · 12 likes Picking up post #116: that is the part I would want checked first. The most useful reply I ever got about Language barriers in accessing was a request to state my…
-
A history of disordered eating: proceeding carefully Replied, post #51 · Wellbeing › Mental health · 5 Jan 2026 · 17 likes Post #50 is right about the mechanism and I think understates the practical bit. If you are in crisis, contact a local emergency or crisis service rather than posting.…
-
Citation sweep results: how many references did not say what was claimed Replied, post #26 · Meta › Wiki maintenance · 4 Jan 2026 · 3 likes This is the answer, and the reason it is the answer is the more useful part.
-
The headache that turns out to be dehydration Replied, post #122 · Nutrition & Training › Hydration & electrolytes · 3 Jan 2026 · 1 like Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them. Old habit: I write down the expected answer before…
-
How to ask about something you suspect is a bad idea Replied, post #40 · Start Here › How to Ask · 2 Jan 2026 · 5 likes On post #36 — agreed on the reasoning, with one qualification. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #28 · Clinical › Bloodwork · 27 Dec 2025 · 15 likes Narrowing post #27, because the general version has more than one answer. On reference intervals I would separate what is worth knowing from what is worth acting on.…
-
Dead volume across syringe and needle combinations Replied, post #41 · Devices › Syringes & needles · 20 Dec 2025 · 31 likes Building on post #38 rather than restating it. On dead volume across syringe, the part that usually goes wrong is that the question is asked as though it has one…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #30 · Clinical › Bloodwork · 16 Dec 2025 · 0 likes On post #26 — agreed on the reasoning, with one qualification. The most useful reply I ever got about panel was a request to state my units. It sounds like pedantry and…
-
Specification in the result column: why that is a meaningful error Replied, post #89 · Analytics › COA interpretation · 15 Dec 2025 · 0 likes A test date preceding a manufacturing date is a clerical error until somebody explains otherwise, and asking is cheap. Most such things are transcription. I have left…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #55 · Wellbeing › Mental health · 26 Nov 2025 · 33 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Request: a diff view for wiki revisions — the long version Replied, post #75 · Meta › Feature requests · 26 Nov 2025 · 10 likes Everything in post #71 holds. The case it does not cover is the one I have. Request from the analytics side: allow a table in a post to be marked as data rather than…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #65 · Compounds › Tirzepatide · 14 Nov 2025 · 3 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
-
A history of disordered eating: proceeding carefully Started this topic · Wellbeing › Mental health · 6 Nov 2025 · 50 likes A history of disordered eating: proceeding carefully Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree…
-
A 40-week log with the measurement method stated Replied, post #31 · Outcomes › Progress reports · 18 Oct 2025 · 21 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Second pass at: Programming during a large energy deficit Replied, post #35 · Nutrition & Training › Resistance training · 11 Oct 2025 · 4 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #44 · Evidence › Preprints · 29 Sep 2025 · 9 likes Adding a null result on Citing a preprint. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #61 · Start Here › How to Ask · 29 Sep 2025 · 31 likes Confirming post #60 from a second method, which matters more than confirming it from a second person. Chromatogram questions: describe the method first. Column type,…
-
Comparing my trajectory with the trial curves, carefully Replied, post #47 · Outcomes › Progress reports · 11 Sep 2025 · 4 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. That is where I would start, not…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #75 · Compounds › Retatrutide · 2 Sep 2025 · 7 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
A preprint whose numbers changed substantially at publication Replied, post #31 · Evidence › Preprints · 26 Aug 2025 · 7 likes Building on post #30 rather than restating it. Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #16 · Practice › Side effects · 3 Aug 2025 · 0 likes Everything in post #12 holds. The case it does not cover is the one I have. My position on Fatigue is current rather than settled. I have revised it once already and I…
-
A ten-fold dose error caught before injection — one year on Replied, post #33 · Devices › Syringes & needles · 2 Aug 2025 · 14 likes Where I part company with post #29, and it is a narrow parting. Drawing air into the vial before withdrawing liquid equalises the pressure and makes the draw easier. It…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #95 · Wellbeing › Mental health · 23 Jul 2025 · 30 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
A field-by-field walk through a certificate of analysis Replied, post #92 · Analytics › COA interpretation · 17 Jul 2025 · 11 likes Post #89 is the version of this I will quote in future. One addition. Checked the field-by-field walk through a certificate claim against the primary source this…
-
Gauge and length selection for subcutaneous injection Replied, post #9 · Devices › Syringes & needles · 3 Jul 2025 · 10 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #76 · Compounds › Tirzepatide · 24 Jun 2025 · 4 likes Post #72 describes the usual case. This is about the unusual one. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #11 · Data & Tools › Datasets · 22 Jun 2025 · 28 likes Speaking only to whether an aggregate as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
-
Sodium, potassium and magnesium when intake drops Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 8 Jun 2025 · 5 likes Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and poor sleep. Attribution from symptoms alone is unreliable.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #62 · Compounds › Retatrutide · 7 Jun 2025 · 6 likes This follows post #59 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #113 · Sourcing › Independent verification · 18 May 2025 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #67 · Practice › Interactions · 30 Apr 2025 · 1 like Reading rather than contributing, but this is the most useful thread I have found on it.
-
Asking about a compound your prescriber has not heard of Replied, post #26 · Clinical › Prescriber conversations · 27 Apr 2025 · 14 likes Understood, and I withdraw the assumption I opened with.
-
Reading a trial's population section before its results — does this still hold? Replied, post #14 · Evidence › Trials · 16 Apr 2025 · 3 likes Post #13 describes the usual case. This is about the unusual one. Nothing in a trial report is medical advice about an individual, and the gap between a population…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #108 · Documentation › Doc review · 16 Apr 2025 · 0 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #30 · Regional › UK & Ireland · 15 Apr 2025 · 4 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Reading order for a first week here, and what to skip until later Replied, post #70 · Start Here › Welcome · 6 Apr 2025 · 12 likes Summarising the reading order thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #110 · Sourcing › Regulatory · 21 Mar 2025 · 13 likes Post #109 is the version of this I will quote in future. One addition. Reporting rather than recommending, on Research-use-only labelling. What happened is above.…
-
Validating a method you did not develop — does this still hold? Replied, post #98 · Analytics › Method validation · 10 Mar 2025 · 31 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Consistent declarations and why they matter more than clever ones Replied, post #162 · Sourcing › Logistics · 10 Mar 2025 · 0 likes Post #159 and I disagree about the size of the effect, not about the direction. The arithmetic on consistent declarations is the easy part and it is where the errors…
-
Second pass at: Regression to the mean in progress reports Replied, post #69 · Research Methods › Statistics · 27 Feb 2025 · 17 likes I have been on both sides of the Regression argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #12 · Practice › Reconstitution · 16 Feb 2025 · 24 likes Saving this. It is the version I will quote when the question comes round again.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #19 · Compounds › Other compounds · 5 Feb 2025 · 0 likes Post #18 answers the question as asked. The question underneath it is different. PT-141 was developed from the same family with a different receptor profile, and it has…
-
Patterns that reliably precede a problem, documented Replied, post #6 · Sourcing › Red flags · 2 Feb 2025 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Building a sensible monitoring schedule with your prescriber Replied, post #65 · Clinical › Bloodwork · 21 Dec 2024 · 25 likes Helpful, and short, which on this subject is harder than long.
-
Gallbladder disease risk with rapid weight loss Replied, post #44 · Clinical › Comorbidities · 16 Dec 2024 · 21 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Coming back to: When to suspect the method rather than the sample Replied, post #10 · Analytics › Method validation · 29 Nov 2024 · 31 likes Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to ask for the procedure identifier rather than the…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #26 · Practice › Interactions · 20 Nov 2024 · 16 likes That is the distinction I keep failing to hold on to. Written down now.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #73 · Clinical › Comorbidities · 21 Oct 2024 · 0 likes Where two conditions pull in opposite directions, that is a clinical judgement rather than a lookup, and it is the kind of question a forum answers worst. I have…
-
Request: a diff view for wiki revisions Replied, post #18 · Meta › Feature requests · 19 Oct 2024 · 3 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. It is one…
-
Reading a supplementary appendix and finding the interesting part Replied, post #6 · Evidence › Trials · 14 Oct 2024 · 9 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #36 · Access › Shortages · 10 Oct 2024 · 0 likes Post #34 and I disagree about the size of the effect, not about the direction. Switching presentation or strength during a shortage is a prescribing decision rather…
-
Why a preprint's supplementary material is often the best part Replied, post #30 · Evidence › Preprints · 19 Sep 2024 · 0 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. Noting…
-
Progressive overload when the scale is falling — one year on Replied, post #57 · Nutrition & Training › Resistance training · 15 Sep 2024 · 29 likes This is the answer, and the reason it is the answer is the more useful part.
-
Reporting a discrepancy without making an allegation Replied, post #59 · Sourcing › Vendor reports · 5 Sep 2024 · 4 likes On post #55 — agreed on the reasoning, with one qualification. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #116 · Research Methods › Statistics · 24 Aug 2024 · 1 like Correlation between two derived quantities that share a component is partly artefactual. It is a common trap in analyses of ratios.
-
Pen wastage and its effect on real cost Replied, post #18 · Access › Pricing · 23 Aug 2024 · 0 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. Cost per milligram is the only comparison that survives format differences, but even…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #76 · Analytics › COA interpretation · 14 Aug 2024 · 7 likes I disagree with the framing of Purity assay versus content assay above, and I think it is a substantive disagreement rather than a terminological one. Setting out why,…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #9 · Safety › Contraindications · 16 Jul 2024 · 0 likes Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest contraindication in this class and it is specific…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #148 · Practice › Dosing & titration · 11 Jul 2024 · 0 likes The arithmetic in post #145 is right; the assumption feeding it is the part to check. Holding a dose indefinitely: the trials did not study indefinite holding at a…
-
The mass-error checker and its intended scope Replied, post #59 · Data & Tools › Calculators · 18 Jun 2024 · 2 likes The parts-per-million mass-error calculation is simple enough to do mentally to one significant figure, which is a good habit because it catches an order-of-magnitude…